课题基金 / 基金详情

DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMIZED STUDY ON EFFICACY OF IBANDRONATE

DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMIZED STUDY ON EFFICACY OF IBANDRONATE
关于伊班膦酸钠疗效的双盲、安慰剂对照、随机研究
批准号：
6117808
负责人：
C. CONRAD JOHNSTON
金额：
$1.7万
依托单位：
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
依托单位国家：
美国
项目类别：
财政年份：
1998
资助国家：
美国
项目状态：
已结题
起止时间：
1998-12-01 至 1999-11-30
来源：
https://reporter.nih.gov/project-details/6117808
关键词：
bone fracture breast neoplasm /cancer diagnosis clinical research diphosphonate drug screening /evaluation female human subject human therapy evaluation oral administration osteoporosis postmenopause skeletal disorder chemotherapy

项目摘要

项目成果

C. CONRAD JOHNSTON的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The purpose of this three year phase III study is to investigate the therapeutic effect Ibandronate in the long term treatment of postmenopausal osteoporosis by evaluating the efficacy of long term intermittent and long termcontinuous oral treatment using the incidence of new vertebral fractures as the primary endpoint. The specific objectives to determine whether Ibandronate prevents fractures and bone loss in women with established postmenopausal osteoporosis, to determine the type of side effects associated with the oral administration of Ibandronate.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ROLE OF SEX STEROIDS IN AGE-RELATED BONE LOSS
RALOXIFENE HCL AND PLACEBO IN PREVENTION OF OSTEOPOROSIS IN POSTMENOPAUSALS
DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMIZED STUDY ON EFFICACY OF IBANDRONATE
RALOXIFENE HCL AND PLACEBO IN PREVENTION OF OSTEOPOROSIS IN POSTMENOPAUSALS